Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure

Growth Hormone and IGF Research

Volumn 10, Issue 6, 2000, Pages 332-341

  Houang, Muriel ^a   Cabrol, Sylvie ^a   Perin, Laurence ^a   Ducos, Bertrand ^b   Bensman, Albert ^a   Le Bouc, Yves ^a,b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Chronic renal failure; Growth hormone; Growth retardation; IGF I; IGFBP; IGFBP 6; Type I IGF receptor

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONSERVATIVE TREATMENT; FEMALE; GROWTH RETARDATION; HEMODIALYSIS; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBERTY; RADIOIMMUNOASSAY; SCHOOL CHILD; WESTERN BLOTTING;

EID: 0034493749     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1054/ghir.2000.0178     Document Type: Article

References (72)

1. Growth retardation in children with chronic renal disease: Scope of the problem
2. Statural growth of children with chronic renal failure on conservative treatment
3. Growth charts for prepubertal children with chronic renal failure due to congenital renal disorders
4. Effect of chronic metabolic acidosis on the growth hormone / IGF I endocrine axis: New cause of growth hormone insensitivity in humans
5. Pathophysiology of growth retardation in children with chronic renal failure
6. Growth and endocrine function after renal transplantation
7. Growth and endocrine function in children with chronic renal failure
8. Renal transplantation in children and adolescents: The 1992 Annual Report of the North American Pediatric Renal Transplant Cooperative Study
9. Factors predictive of sustained growth in children after renal transplantation
10. Growth hormone and insulin-like growth factor I in chronic renal failure. Pathophysiology and rationale for growth hormone treatment
11. Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after transplantation
12. Immunoreactive IGF II in serum of healthy subjects and patients with growth hormone disturbances and uremia
13. Serum somatomedin levels in adults with chronic renal failure: The importance of measuring insulin-like growth factor I (IGF I) and IGF II in acid-chromatographed uremic serum
14. Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: Evidence for reduced secretion of IGFs
15. Uremia reduces insulin-like growth factor I, increases insulin-like growth factor II and modifies their serum protein binding
16. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein (IGFBP) in uremia
17. Insulin-like growth factor-1, growth hormone-dependent insulin-like growth factor-binding protein and growth in children with chronic renal failure
18. Insulin-like growth factor I and its binding protein during a low protein diet in chronic renal failure
19. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate
20. Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease
21. Twenty four hours plasma growth hormone (GH) profiles, urinary GH excretion and plasma insulin-like growth factor I and II levels in prepubertal children with chronic renal insufficiency and severe growth retardation
22. Decreased bioavailability of insulin-like growth factor I, a cause of catabolism in hemodialysis patients
23. Somatomedin and growth after renal transplantation
24. Somatomedin activity and inorganic sulfate in children undergoing hemodialysis
25. Somatomedin in growth disorders and chronic renal insufficiency in children
26. Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure
27. Improvement of growth and food utilisation by human recombinant growth hormone in uremia
28. Effect of two years of growth hormone treatment in short children with renal disease
29. Growth hormone treatment in short children with chronic renal failure and after renal transplantation: Combined data from European clinical trials
30. Placebo-controlled double blind crossover trial of growth hormone treatment in prepubertal children with chronic renal failure
31. Stimulating growth in uremic children
32. Growth hormone treatment of children with chronic renal insufficiency, end stage renal disease and following renal transplantation - Update 1997
33. Growth-stimulating effects of recombinant human growth hormone in children with end stage renal disease
34. Post graft development of short children treated with growth hormone before kidney graft
35. The 10th edition of the recommended dietary allowances
36. Energy and protein requirements
37. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents
38. Molecular forms of serum insulin-like growth factor (IGF) binding proteins in man: Relationships with growth hormone and IGFs and physiological significance
39. The development of the reproductive system
40. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive studies
41. Evidence that limited proteolysis of insulin-like growth factor binding protein 3 (IGFBP-3) occurs in the normal state outside the bloodstream
42. A simple assay for proteolysis of IGFBP-3
43. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF binding proteins (IGFBPs) produced by rat liver in culture. Estimation of serum IGFBP levels
44. Characteristics of human erythrocyte insulin receptors
45. Carbohydrate intake affects insulin binding to human erythrocytes in normal weight subjects but not in subjects with family obesity
46. Ligand: A versatile computerized approach for the characterization of ligand binding systems
47. The attractions of proteins for small molecules and ions
48. Lactogenic and somatotrop binding sites in liver membranes of rats with renal insufficiency
49. Plasma growth hormone binding is low in uremic children
50. Reduced hepatic growth hormone (GH) receptor gene expression and increase in plasma GH binding protein in experimental uremia
51. Expression of insulin-like growth factor I in uremic rats: Growth hormone resistance and nutritional intake
52. Differential regulation of IGF I and IGF BP-1 mRNAs by amino acid availability and growth hormone in rat hepatocyte primary culture
53. Dietary protein restriction decreases insulin-like growth factor I independent of insulin and liver growth hormone binding
54. Regulation of insulin-like growth factor I (IGF I) and IGF-binding protein 1 gene transcription by hormones and amino-acids in rat hepatocytes
55. Insulin-like growth factors and their binding proteins: Biological actions
56. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
57. Evidence of enzymatic degradation of insulin-like growth factor binding proteins
58. The induction of a specific protease for insulin-like growth factor binding protein 3 in the circulation during severe illness
59. Insulin-like growth factor binding protein 3 proteolysis is induced after elective surgery
60. Proteolysis of insulin-like growth factor binding protein 3 in human immunodeficiency virus-positive children who fail to thrive
61. Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3
62. Protease-induced alterations of insulin-like growth factor binding protein-3 as detected by radioimmunoassay. Agreement with ligand blotting data
63. The insulin-like growth factor axis and growth in children with chronic renal failure: A report of the southwest pediatric nephrology study group
64. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF I and insulin
65. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults
66. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein (IGFBP)-1 and -2 gene expression in experimental uremia
67. Insulin-like growth factor binding protein-6 levels are elevated in serum of children with chronic renal failure: A report of the southwest pediatric nephrology study group
68. Resistance to recombinant human IGF I in skeletal muscle of rats with chronic renal failure
69. Erythrocytes from patients with low serum concentrations of IGF I have an increase in receptor sites for IGF I
70. Modulation of IGF I receptors by exogenous hGH treatment in constitutionally short children
71. Increased number of IGF I receptors on erythrocytes of women with polycystic ovarian syndrome